Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer.
- DOI
- 10.1016/j.breast.2026.104901
- Published
- 2026 Oct
- Container
- Breast (Edinburgh, Scotland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.breast.2026.104901,
title = {Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer.},
author = {Trapani D and Deshmukh SK and Wu S and Xiu J and Jayachandran P and Gandhi S and Lin NU and Curigliano G and Spanheimer PM and Abravanel DL and Radovich M and Lustberg M and Graff SL and Sledge GW Jr and Tolaney SM and Leone JP},
year = {2026},
journal = {Breast (Edinburgh, Scotland)},
doi = {10.1016/j.breast.2026.104901},
url = {https://doi.org/10.1016/j.breast.2026.104901}
}RIS
TY - JOUR TI - Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer. AU - Trapani D AU - Deshmukh SK AU - Wu S AU - Xiu J AU - Jayachandran P AU - Gandhi S AU - Lin NU AU - Curigliano G AU - Spanheimer PM AU - Abravanel DL AU - Radovich M AU - Lustberg M AU - Graff SL AU - Sledge GW Jr AU - Tolaney SM AU - Leone JP PY - 2026 JO - Breast (Edinburgh, Scotland) DO - 10.1016/j.breast.2026.104901 UR - https://doi.org/10.1016/j.breast.2026.104901 ER -
APA
D, T., SK, D., S, W., J, X., P, J., S, G., NU, L., G, C., PM, S., DL, A., M, R., M, L., SL, G., Jr, S. G., SM, T., & JP, L. (2026). Molecular and immune profiling of HER2-low, HER2 ultra-low, and HER2-null male breast cancer.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2026.104901
Source records
- pubmed · retrieved 2026-09-26T03:23:41.159Z
- europe-pmc · retrieved 2026-09-26T03:23:41.151Z
- doaj · retrieved 2026-09-26T03:23:41.127Z